1875 — TOT Biopharm International Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for TOT Biopharm International Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	226	153	458	352	381
Net Total Accounts Receivable
Net Total Receivables	6.75	27	62.7	143	193
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	249	306	677	693	743
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	311	379	563	712	738
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	641	710	1,262	1,426	1,509
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	52.7	261	275	382	415
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	58.8	375	548	739	779
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	582	335	714	687	730
Total Liabilities & Shareholders' Equity	641	710	1,262	1,426	1,509
Total Common Shares Outstanding